T cell correction pipeline for Inborn Errors of Immunity
Mamia, K.; Kolbeinsdottir, S.; Li, Z.; Labun, K.; Komisarczuk, A.; Keskitalo, S.; Reint, G.; Haugen, F. H.; Lindestad, B. O.; Gjerdingen, T. J.; Tuhkala, A.; Ervik, C. W.; Kopcil, P.; Fatkhutdinov, N.; Szymanska, M.; Tolo, E.; Glumoff, V.; Saarela, J.; Michelsen, T. M.; Schalin-Jantti, C.; Olweus, J.; Leinonen, E.; Varjosalo, M.; Valen, E.; Hautala, T.; Enge, M.; Martelius, T.; Dahal-Koirala, S.; Haapaniemi, E.
Show abstract
CRISPR/Cas9 gene editing technology is a promising tool for correcting pathogenic variants for autologous cell therapies for Inborn Errors of Immunity (IEI). The present IEI correction strategies mainly focus on the knock-in of therapeutic cDNAs, or knockout of the disease-causing gene when feasible. These strategies address many single-gene defects but may disrupt gene expression and require significant optimization for each newly discovered IEI-causing gene, highlighting the need for complementary platforms that can precisely correct diverse pathogenic variants. Here, we present a safe and efficient T cell single nucleotide variant (SNV) correction pipeline based on homology-directed repair (HDR), suitable for diverse monogenic mutations. By using founder mutations of Deficiency of ADA2 (DADA2), Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and Cartilage Hair Hypoplasia (CHH) as IEI models, we show that our pipeline can achieve up to 80% bi-allelic editing, with resultant functional correction of the disease phenotype in patient T cells. We do not find detectable pre-malignant off-target effects or karyotypic, transcriptomic or proteomic aberrations upon profiling patient T cells with GUIDE-seq, single cell RNA sequencing, PacBio based long-read whole genome sequencing, and high-throughput proteomics. This study demonstrates that HDR-based SNV editing is a safe and effective option for IEI T cell correction and that it could be developed to an autologous T cell therapy, as the presented protocol is scalable for a GMP-compatible workflow. This study is a step towards the development of gene correction platform that targets a broad number of monogenic mutations. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=140 SRC="FIGDIR/small/610811v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@1f1eb47org.highwire.dtl.DTLVardef@18dbcc2org.highwire.dtl.DTLVardef@63862dorg.highwire.dtl.DTLVardef@1fe1561_HPS_FORMAT_FIGEXP M_FIG GRAPHICAL ABSTRACT C_FIG
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Functional Screening in human HSPCs identifies optimized protein-based enhancers of Homology Directed Repair 96%
- Adenine base editing is an efficient approach to restore function in FA patient cells without double-stranded DNA breaks 96%
- Simultaneous inhibition of DNA-PK and Pol{Theta} improves integration efficiency and precision of genome editing 95%
Similar papers in this journal
- An aptamer-mediated base editing platform for simultaneous knock-in and multiple gene knockout for allogeneic CAR-T cells generation 95%
- Comparative analysis of CRISPR off-target activity discovery tools following ex vivo editing of CD34+ hematopoietic stem and progenitor cells 94%
- CD33 Epitope Editing Unlocks UM171-Expanded Cord Blood Grafts for AML Immunotherapy 94%
Similar papers in this journal
- In vivo affinity maturation of the HIV-1 Env-binding domain of CD4 92%
- Collagen-binding IL-12 expressing STEAP1 CAR-T cells reduce toxicity and eradicate mouse prostate cancer in combination with checkpoint inhibitors 92%
- Human spinal cord organoids exhibiting neural tube morphogenesis for a quantifiable drug screening system of neural tube defects 92%
Similar papers in this journal
- Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV–Associated Hodgkin Lymphoma 95%
- A multimorphic variant in ThPOK causes a novel human disease characterized by T cell abnormalities, immunodysregulation, allergy, and fibrosis 93%
- Single-cell profiling identifies a spectrum of human unconventional intraepithelial T lineage cells 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.